Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Development of a crosswalk for pain interference measured by the BPI and PROMIS pain interference short form.
Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins.
Role of socioeconomic position in multiple sclerosis etiology.
CD43 Functions as an E-Selectin Ligand for Th17 Cells In Vitro and Is Required for Rolling on the Vascular Endothelium and Th17 Cell Recruitment during Inflammation In Vivo.
The effectiveness of percutaneous balloon compression in the treatment of trigeminal neuralgia in patients with multiple sclerosis.
Placebo controlled trials in neuromyelitis optica are needed and ethical.
Oral Contraceptives and Multiple Sclerosis/Clinically Isolated Syndrome Susceptibility.
Respiratory tract rather than cutaneous atopic allergy inversely associate with multiple sclerosis: A case-control study.
Clinical prospective study of visual function in patients with acute optic neuritis.
Predictors of effectiveness of multidisciplinary rehabilitation treatment on motor dysfunction in multiple sclerosis.
Interferon-beta-1a treatment has a positive effect on quality of life of relapsing-remitting multiple sclerosis: Results from a longitudinal study.
Development of a neuroprotective peptide that preserves survival pathways by preventing Kidins220/ARMS calpain processing induced by excitotoxicity.
Upregulation of ciliary neurotrophic factor in astrocytes by aspirin: Implications for remyelination in multiple sclerosis.
Memory in multiple sclerosis is linked to glutamate concentration in grey matter regions.
Fingolimod therapy for multiple sclerosis.
Neutrophils Mediate Blood-Spinal Cord Barrier Disruption in Demyelinating Neuroinflammatory Diseases.
Circulating Levels of Interleukin-35 in Patients with Multiple Sclerosis: Evaluation of the Influences of FOXP3 Gene Polymorphism and Treatment Program.
Dendritic cells in multiple sclerosis: key players in the immunopathogenesis, key players for new cellular immunotherapies?
Experimental Autoimmune Encephalomyelitis in Marmosets.
Current and emerging therapies for multiple sclerosis.
Assessment of Optic Nerve Impairment in Patients with Neuromyelitis Optica by MR Diffusion Tensor Imaging.
First-dose effects of fingolimod: Pooled safety data from three phase 3 studies.
EOP, a Newly Synthesized Ethyl Pyruvate Derivative, Attenuates the Production of Inflammatory Mediators via p38, ERK and NF-κB Pathways in Lipopolysaccharide-Activated BV-2 Microglial Cells.
Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica.
Teriflunomide - a new oral agent for multiple sclerosis treatment.

Pages